We are live on ! Find out more
TGA

TPG GP A Portfolio holdings

AUM $3.68B
1-Year Est. Return 14.99%
This Fund
S&P 500
This Quarter Est. Return
+0.55%
1 Year Est. Return
+14.99%
3 Year Est. Return
+76.26%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.1B
AUM Growth
-$1.01B
Cap. Flow
-$856M
Cap. Flow %
-16.81%
Top 10 Hldgs %
65.64%
Holding
41
New
3
Increased
9
Reduced
12
Closed
4

Top Buys

Rank Stock Value
1
EDR
Endeavor Group Holdings, Inc.
EDR
+$78.3M
2
CRL icon
Charles River Laboratories
CRL
+$66M
3
ADI icon
Analog Devices
ADI
+$61.4M
4
AMZN icon
Amazon
AMZN
+$54.4M
5
VMC icon
Vulcan Materials
VMC
+$22.8M

Top Sells

Rank Stock Value
1
CNVY
Convey Health Solutions Holdings, Inc.
CNVY
+$575M
2
LW icon
Lamb Weston
LW
+$150M
3
ROST icon
Ross Stores
ROST
+$105M
4
ELV icon
Elevance Health
ELV
+$95M
5
PCVX icon
Vaxcyte
PCVX
+$82.2M

Sector Composition

Rank Sector Weight
1 Healthcare 32.82%
2 Technology 17.57%
3 Consumer Discretionary 14.41%
4 Real Estate 9.46%
5 Communication Services 9.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FWONA icon
26
Liberty Media Series A
FWONA
$22.4B
$41.1M 0.81%
802,537
+9,223
+1% +$469K
FNF icon
27
Fidelity National Financial
FNF
$13.5B
$40.6M 0.8%
1,078,369
-880,180
-45% -$33M
OPTU
28
Optimum Communications Inc
OPTU
$350M
$38.1M 0.75%
8,282,378
– –
MPLX icon
29
MPLX
MPLX
$57.4B
$31.8M 0.62%
968,852
-427,153
-31% -$14M
NRDY icon
30
Nerdy
NRDY
$105M
$26.4M 0.52%
11,723,250
-1,500,000
-11% -$3.26M
AMRX icon
31
Amneal Pharmaceuticals
AMRX
$5.67B
$24.5M 0.48%
12,328,767
-3,884,600
-24% -$8.71M
VMC icon
32
Vulcan Materials
VMC
$36B
$23.4M 0.46%
+133,629
New +$22.8M
RLYB icon
33
Rallybio
RLYB
$88.2M
$19.9M 0.39%
378,552
– –
FUSN
34
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
$8.04M 0.16%
2,551,794
– –
VCSA
35
DELISTED
Vacasa, Inc. Class A Common Stock
VCSA
$5.39M 0.11%
213,792
– –
UXIN
36
Uxin Ltd
UXIN
$337M
$2.76M 0.05%
95,946
– –
NRDY.WS
37
DELISTED
Nerdy Inc. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
NRDY.WS
$46K ﹤0.01%
200,000
-300,000
-60% -$80K
RPID icon
38
Rapid Micro Biosystems
RPID
$103M
– –
-47,935
Closed -$155K
TRVI icon
39
Trevi Therapeutics
TRVI
$2.46B
– –
-251,780
Closed -$388K
STSA
40
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
– –
-1,885,939
Closed -$11.3M
CNVY
41
DELISTED
Convey Health Solutions Holdings, Inc.
CNVY
– –
-54,699,513
Closed -$575M
1
2

Similar funds

SLG
Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return
EPIM
Evelyn Partners Investment Management London $3.68B AUM 21.15% 1-Year Est. Return
HIM
Hillsdale Investment Management Toronto, Ontario, Canada $3.68B AUM 62.12% 1-Year Est. Return
BB
Busey Bank Urbana, Illinois $3.68B AUM 26.6% 1-Year Est. Return
MTIM
Marathon Trading Investment Management Radnor, Pennsylvania $3.67B AUM 21.97% 1-Year Est. Return
CAM
Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return
MMA
Mizuho Markets Americas New York $3.66B AUM 25.21% 1-Year Est. Return
GCM
Gates Capital Management New York $3.66B AUM 12.63% 1-Year Est. Return

TPG GP A's Q4 2022 Portfolio in Review

As of Q4 2022, TPG GP A held 41 positions worth $5.1B, down 17% from $6.11B the previous quarter. Its ten largest holdings account for 66% of the portfolio.

TPG GP A withdrew a net $856M in Q4 2022, closing 4 positions and reducing 12 holdings. Its most notable exit was Convey Health Solutions Holdings, Inc., an estimated $575M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 45% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, TPG GP A opened a new position in Charles River Laboratories worth $65.9M.

  • TPG GP A's largest Q4 2022 buy was Charles River Laboratories: 302,263 shares worth $65.9M.
  • TPG GP A added most to Endeavor Group Holdings, Inc. in Q4 2022, an estimated $78.3M increase.
  • TPG GP A's biggest Q4 2022 reduction was Lamb Weston, cutting an estimated $150M.
  • TPG GP A fully exited Convey Health Solutions Holdings, Inc. in Q4 2022, selling an estimated $575M.
  • TPG GP A's ten largest holdings make up 66% of its $5.1B portfolio in Q4 2022.
  • TPG GP A opened 3 new positions and closed 4 in Q4 2022.
  • TPG GP A's portfolio value fell 17% quarter-over-quarter to $5.1B.

Based on TPG GP A's 13F filing for Q4 2022, filed 14 Feb 2023.